129 related articles for article (PubMed ID: 11448665)
1. A new era in type 2 diabetes mellitus treatment?
Laws A
Am J Med; 2001 Jul; 111(1):71-2. PubMed ID: 11448665
[No Abstract] [Full Text] [Related]
2. [Reducing postprandial glucose levels. Glucosidase antagonists].
Neye H
Pharm Unserer Zeit; 2002; 31(3):272-8. PubMed ID: 12071124
[No Abstract] [Full Text] [Related]
3. [Continuation 50. Type 2 diabetes: possibilities and limitations of pharmacological therapy].
Kellerer M; Jakob S; Linn T; Haslbeck M
MMW Fortschr Med; 2003 Dec; 145(51-52):I-X; quiz XI-XII. PubMed ID: 14974337
[No Abstract] [Full Text] [Related]
4. [Drug therapy of type 2 diabetes: insulin sensitizers improve results].
Stadler HJ
Pflege Z; 1999 Nov; 52(11):772-5. PubMed ID: 10788929
[No Abstract] [Full Text] [Related]
5. Effect of alpha-inhibitors on blood glucose and insulin levels.
Laube H; Federlin K; Hillebrand I
Adv Exp Med Biol; 1988; 246():287-93. PubMed ID: 3074658
[No Abstract] [Full Text] [Related]
6. Miglitol and hepatotoxicity in type 2 diabetes mellitus.
Carlson RF
Am Fam Physician; 2000 Jul; 62(2):315, 318. PubMed ID: 10929699
[No Abstract] [Full Text] [Related]
7. Improving management of type 2 diabetes mellitus: 1. alpha-Glucosidase inhibitors.
Kuritzky L; Samraj G; Quillen DM
Hosp Pract (1995); 1999 Sep; 34(10):43-6. PubMed ID: 10901748
[No Abstract] [Full Text] [Related]
8. Miglitol for type 2 diabetes mellitus.
Med Lett Drugs Ther; 1999 May; 41(1053):49-50. PubMed ID: 10368700
[No Abstract] [Full Text] [Related]
9. [Therapy decision based on the glucose triad. Drug treatment of type 2 diabetes].
Hanefeld M; Fischer S
MMW Fortschr Med; 2003 Feb; 145(9):30-4. PubMed ID: 12666526
[TBL] [Abstract][Full Text] [Related]
10. Oral pharmacologic management of type 2 diabetes.
Riddle MC
Am Fam Physician; 1999 Dec; 60(9):2613-20. PubMed ID: 10605995
[TBL] [Abstract][Full Text] [Related]
11. Type 2 diabetes: glycemic targets and oral therapies for older patients.
Lardinois CK
Geriatrics; 1998 Nov; 53(11):22-3, 27-8, 33-4 passim. PubMed ID: 9824974
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetic, pharmacological, and clinical profile of miglitol (SEIBULE), a novel alpha-glucosidase inhibitor].
Kuboyama N; Hayashi I; Yamaguchi T
Nihon Yakurigaku Zasshi; 2006 Mar; 127(3):223-32. PubMed ID: 16651808
[No Abstract] [Full Text] [Related]
13. [Risk of complications in the diabetic patient. Postprandial blood glucose peaks as deciding factor].
MMW Fortschr Med; 2000 Jul; 142(26-27):54-5. PubMed ID: 10929491
[No Abstract] [Full Text] [Related]
14. New oral agents for type 2 diabetes.
Krentz AJ
Clin Med (Lond); 2007 Apr; 7(2):117-8. PubMed ID: 17491497
[No Abstract] [Full Text] [Related]
15. alpha-Glucosidase inhibition in the treatment of diabetes mellitus.
Dimitriadis G; Raptis S
Horm Metab Res Suppl; 1992; 26():42-9. PubMed ID: 1490691
[No Abstract] [Full Text] [Related]
16. Potential pharmacokinetics interference between alpha-glucosidase inhibitors and other oral antidiabetic agents.
Scheen AJ; Lefèbvre PJ
Diabetes Care; 2002 Jan; 25(1):247-8. PubMed ID: 11772929
[No Abstract] [Full Text] [Related]
17. Type 2 diabetes management: a comprehensive clinical review of oral medications.
Quillen DM; Kuritzky L
Compr Ther; 2002; 28(1):50-61. PubMed ID: 11894443
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic options for the management of type 2 diabetes mellitus.
Takiya L; Chawla S
Am J Manag Care; 2002 Nov; 8(11):1009-23; quiz 1024-7. PubMed ID: 12437315
[TBL] [Abstract][Full Text] [Related]
19. Managing type 2 diabetes. A look at the newer agents.
Larmore SS
JAAPA; 1999 Jun; 12(6):47-8, 51-4, 57. PubMed ID: 10728087
[No Abstract] [Full Text] [Related]
20. [Alpha-glucosidase inhibitor for type 2 diabetic patients. Clinical study with miglitol].
Fehmann HC
MMW Fortschr Med; 2000 May; 142(21):55. PubMed ID: 10872296
[No Abstract] [Full Text] [Related]
[Next] [New Search]
